Despite the imbalanced sample sizes, the automated statistical testing, based on a 2 × 2 contingency framework, yielded a highly significant p -value (0.093 for the chi-square test) and an odds ratio of 0.0 (95% CI: 0.045–0.193), indicating a marked disparity in KRAS mutation representation at the exploratory stage.
← all excerpts
Artificial Intelligence-Enhanced Molecular Profiling of JAK-STAT Pathway Alterations in FOLFOX-Treated Early-Onset Colorectal Cancer.
1
—
—